WST - Capitalizing In Growth Prospects Banks Kimberly MacKay Acquires In West Pharmaceutical Servs Stock Options | Benzinga
A noteworthy insider acquisition was disclosed on February 22, as MacKay, SVP at West Pharmaceutical Servs (NYSE:WST), reported the acquisition of stock options for 2,411 shares.
What Happened: MacKay, SVP at West Pharmaceutical Servs, acquired stock options for 2,411 shares of WST. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday. The options allow MacKay to buy the company's stock at $350.18 per share.
During Friday's morning session, West Pharmaceutical Servs shares down by 0.0%, currently priced at $359.9. Considering the current price, MacKay's 2,411 shares have a total value of $23,434.
Discovering West Pharmaceutical Servs: A Closer Look
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Financial Milestones: West Pharmaceutical Servs's Journey
Revenue Growth: West Pharmaceutical Servs's revenue growth over a period of 3 months has been noteworthy. As of 31 December, ...